Janis Naeve, PhD
Janis Naeve, Managing Director of Amgen Ventures, joined Amgen in 2005. She directs the company’s corporate venture capital fund. She directs the fund’s investment in early-stage biotechnology companies focused on discovering and developing human therapeutics. From 2002-2005, Janis was Director of Corporate Development at X-Ceptor Therapeutics which was acquired by Exelixis. Prior to this she was Director of Business Development at Aurora Biosciences where she led transactions for the ion channel technology business unit and managed the collaborations with Pfizer, Merck, Lilly, and Bristol Myers-Squibb. Janis holds a PhD in pathology from University of Southern California and completed a post-doctoral fellowship at the California Institute of Technology.